Nova Mentis Life Science Corp.
Nova Mentis Life Science Corp. (NMLSF) Stock Competitors & Peer Comparison
See (NMLSF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NMLSF | $0.08 | +43.64% | 2.9M | -1.97 | -$0.04 | N/A |
| NONOF | $36.38 | +2.15% | 162.2B | 10.34 | $3.53 | +4.77% |
| CSLLY | $24.23 | +1.16% | 96.2B | 16.13 | $1.54 | +2.93% |
| UCBJY | $144.08 | +1.74% | 55.3B | 31.57 | $4.60 | +0.54% |
| UCBJF | $281.70 | -7.63% | 53.6B | 30.62 | $9.20 | +0.56% |
| ARGNF | $839.05 | +2.96% | 51.9B | 42.90 | $19.56 | N/A |
| CMXHF | $97.49 | -0.47% | 47.3B | 15.80 | $6.17 | +2.98% |
| WXIBF | $5.25 | +14.13% | 21.7B | 37.50 | $0.14 | N/A |
| WXXWY | $8.55 | +2.76% | 17.3B | 29.32 | $0.29 | N/A |
| IVBXF | $9.75 | -4.69% | 16.8B | 97.50 | $0.10 | N/A |
Stock Comparison
NMLSF vs NONOF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, NONOF has a market cap of 162.2B. Regarding current trading prices, NMLSF is priced at $0.08, while NONOF trades at $36.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas NONOF's P/E ratio is 10.34. In terms of profitability, NMLSF's ROE is +41.60%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, NMLSF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check NONOF's competition here
NMLSF vs CSLLY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CSLLY has a market cap of 96.2B. Regarding current trading prices, NMLSF is priced at $0.08, while CSLLY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CSLLY's P/E ratio is 16.13. In terms of profitability, NMLSF's ROE is +41.60%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, NMLSF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CSLLY's competition here
NMLSF vs UCBJY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, UCBJY has a market cap of 55.3B. Regarding current trading prices, NMLSF is priced at $0.08, while UCBJY trades at $144.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas UCBJY's P/E ratio is 31.57. In terms of profitability, NMLSF's ROE is +41.60%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, NMLSF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check UCBJY's competition here
NMLSF vs UCBJF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, UCBJF has a market cap of 53.6B. Regarding current trading prices, NMLSF is priced at $0.08, while UCBJF trades at $281.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas UCBJF's P/E ratio is 30.62. In terms of profitability, NMLSF's ROE is +41.60%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, NMLSF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check UCBJF's competition here
NMLSF vs ARGNF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ARGNF has a market cap of 51.9B. Regarding current trading prices, NMLSF is priced at $0.08, while ARGNF trades at $839.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ARGNF's P/E ratio is 42.90. In terms of profitability, NMLSF's ROE is +41.60%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, NMLSF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ARGNF's competition here
NMLSF vs CMXHF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CMXHF has a market cap of 47.3B. Regarding current trading prices, NMLSF is priced at $0.08, while CMXHF trades at $97.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CMXHF's P/E ratio is 15.80. In terms of profitability, NMLSF's ROE is +41.60%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, NMLSF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CMXHF's competition here
NMLSF vs WXIBF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, WXIBF has a market cap of 21.7B. Regarding current trading prices, NMLSF is priced at $0.08, while WXIBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas WXIBF's P/E ratio is 37.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to WXIBF's ROE of +0.10%. Regarding short-term risk, NMLSF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check WXIBF's competition here
NMLSF vs WXXWY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, WXXWY has a market cap of 17.3B. Regarding current trading prices, NMLSF is priced at $0.08, while WXXWY trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas WXXWY's P/E ratio is 29.32. In terms of profitability, NMLSF's ROE is +41.60%, compared to WXXWY's ROE of +0.10%. Regarding short-term risk, NMLSF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check WXXWY's competition here
NMLSF vs IVBXF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, IVBXF has a market cap of 16.8B. Regarding current trading prices, NMLSF is priced at $0.08, while IVBXF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas IVBXF's P/E ratio is 97.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to IVBXF's ROE of +0.08%. Regarding short-term risk, NMLSF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check IVBXF's competition here
NMLSF vs GNMSF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, GNMSF has a market cap of 16.5B. Regarding current trading prices, NMLSF is priced at $0.08, while GNMSF trades at $267.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas GNMSF's P/E ratio is 17.40. In terms of profitability, NMLSF's ROE is +41.60%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, NMLSF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check GNMSF's competition here
NMLSF vs SBHMY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SBHMY has a market cap of 15.8B. Regarding current trading prices, NMLSF is priced at $0.08, while SBHMY trades at $17.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SBHMY's P/E ratio is 28.02. In terms of profitability, NMLSF's ROE is +41.60%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, NMLSF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SBHMY's competition here
NMLSF vs SBMFF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SBMFF has a market cap of 14.8B. Regarding current trading prices, NMLSF is priced at $0.08, while SBMFF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SBMFF's P/E ratio is 27.67. In terms of profitability, NMLSF's ROE is +41.60%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, NMLSF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SBMFF's competition here
NMLSF vs BRRGF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, NMLSF is priced at $0.08, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, NMLSF's ROE is +41.60%, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, NMLSF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for NMLSF.Check BRRGF's competition here
NMLSF vs AAVXF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, NMLSF is priced at $0.08, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, NMLSF's ROE is +41.60%, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, NMLSF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check AAVXF's competition here
NMLSF vs TRSBF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, TRSBF has a market cap of 8.4B. Regarding current trading prices, NMLSF is priced at $0.08, while TRSBF trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas TRSBF's P/E ratio is 25.43. In terms of profitability, NMLSF's ROE is +41.60%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, NMLSF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check TRSBF's competition here
NMLSF vs ODTC Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, NMLSF is priced at $0.08, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ODTC's P/E ratio is 1.07. In terms of profitability, NMLSF's ROE is +41.60%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, NMLSF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ODTC's competition here
NMLSF vs AKBLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, AKBLF has a market cap of 7.3B. Regarding current trading prices, NMLSF is priced at $0.08, while AKBLF trades at $36.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas AKBLF's P/E ratio is 43.49. In terms of profitability, NMLSF's ROE is +41.60%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, NMLSF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check AKBLF's competition here
NMLSF vs REGMF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, NMLSF is priced at $0.08, while REGMF trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas REGMF's P/E ratio is -31.65. In terms of profitability, NMLSF's ROE is +41.60%, compared to REGMF's ROE of +0.33%. Regarding short-term risk, NMLSF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check REGMF's competition here
NMLSF vs ABCZF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, NMLSF is priced at $0.08, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, NMLSF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ABCZF's competition here
NMLSF vs LABFF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, NMLSF is priced at $0.08, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas LABFF's P/E ratio is 28.95. In terms of profitability, NMLSF's ROE is +41.60%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, NMLSF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check LABFF's competition here
NMLSF vs SHJBF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, NMLSF is priced at $0.08, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, NMLSF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SHJBF's competition here
NMLSF vs BRCTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, NMLSF is priced at $0.08, while BRCTF trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BRCTF's P/E ratio is 30.89. In terms of profitability, NMLSF's ROE is +41.60%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, NMLSF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BRCTF's competition here
NMLSF vs CAMRF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, NMLSF is priced at $0.08, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CAMRF's P/E ratio is 42.31. In terms of profitability, NMLSF's ROE is +41.60%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, NMLSF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CAMRF's competition here
NMLSF vs ASPHF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, NMLSF is priced at $0.08, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to ASPHF's ROE of -1.40%. Regarding short-term risk, NMLSF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ASPHF's competition here
NMLSF vs GNNSF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, NMLSF is priced at $0.08, while GNNSF trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, NMLSF's ROE is +41.60%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, NMLSF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check GNNSF's competition here
NMLSF vs INCPF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, NMLSF is priced at $0.08, while INCPF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas INCPF's P/E ratio is -102.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to INCPF's ROE of -0.03%. Regarding short-term risk, NMLSF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check INCPF's competition here
NMLSF vs TLPPF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, TLPPF has a market cap of 3B. Regarding current trading prices, NMLSF is priced at $0.08, while TLPPF trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas TLPPF's P/E ratio is -446.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, NMLSF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check TLPPF's competition here
NMLSF vs ZLDPF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ZLDPF has a market cap of 3B. Regarding current trading prices, NMLSF is priced at $0.08, while ZLDPF trades at $42.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ZLDPF's P/E ratio is 3.04. In terms of profitability, NMLSF's ROE is +41.60%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, NMLSF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ZLDPF's competition here
NMLSF vs MPSYF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, NMLSF is priced at $0.08, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, NMLSF's ROE is +41.60%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, NMLSF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check MPSYF's competition here
NMLSF vs GENSF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, GENSF has a market cap of 2.3B. Regarding current trading prices, NMLSF is priced at $0.08, while GENSF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas GENSF's P/E ratio is 37.23. In terms of profitability, NMLSF's ROE is +41.60%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, NMLSF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check GENSF's competition here
NMLSF vs BVNRY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, NMLSF is priced at $0.08, while BVNRY trades at $9.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BVNRY's P/E ratio is 10.72. In terms of profitability, NMLSF's ROE is +41.60%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, NMLSF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BVNRY's competition here
NMLSF vs BVNKF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BVNKF has a market cap of 2.2B. Regarding current trading prices, NMLSF is priced at $0.08, while BVNKF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BVNKF's P/E ratio is 10.40. In terms of profitability, NMLSF's ROE is +41.60%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, NMLSF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BVNKF's competition here
NMLSF vs GLPGF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, NMLSF is priced at $0.08, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, NMLSF's ROE is +41.60%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, NMLSF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check GLPGF's competition here
NMLSF vs HBMHF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, HBMHF has a market cap of 2.1B. Regarding current trading prices, NMLSF is priced at $0.08, while HBMHF trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas HBMHF's P/E ratio is 28.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, NMLSF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check HBMHF's competition here
NMLSF vs ASCLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ASCLF has a market cap of 2B. Regarding current trading prices, NMLSF is priced at $0.08, while ASCLF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ASCLF's P/E ratio is -47.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, NMLSF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ASCLF's competition here
NMLSF vs MEOBF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, MEOBF has a market cap of 2B. Regarding current trading prices, NMLSF is priced at $0.08, while MEOBF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas MEOBF's P/E ratio is -15.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to MEOBF's ROE of -0.18%. Regarding short-term risk, NMLSF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check MEOBF's competition here
NMLSF vs ONTTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, NMLSF is priced at $0.08, while ONTTF trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ONTTF's P/E ratio is -8.32. In terms of profitability, NMLSF's ROE is +41.60%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, NMLSF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ONTTF's competition here
NMLSF vs BIESF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, NMLSF is priced at $0.08, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BIESF's P/E ratio is -44.44. In terms of profitability, NMLSF's ROE is +41.60%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, NMLSF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BIESF's competition here
NMLSF vs PHMMF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, NMLSF is priced at $0.08, while PHMMF trades at $92.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas PHMMF's P/E ratio is 40.08. In terms of profitability, NMLSF's ROE is +41.60%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, NMLSF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check PHMMF's competition here
NMLSF vs SNBIF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, NMLSF is priced at $0.08, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, NMLSF's ROE is +41.60%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, NMLSF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NMLSF.Check SNBIF's competition here
NMLSF vs CSPHF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CSPHF has a market cap of 1.3B. Regarding current trading prices, NMLSF is priced at $0.08, while CSPHF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CSPHF's P/E ratio is -21.53. In terms of profitability, NMLSF's ROE is +41.60%, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, NMLSF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CSPHF's competition here
NMLSF vs MDCLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, NMLSF is priced at $0.08, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, NMLSF's ROE is +41.60%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, NMLSF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check MDCLF's competition here
NMLSF vs PHGUF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, NMLSF is priced at $0.08, while PHGUF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas PHGUF's P/E ratio is -170.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, NMLSF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check PHGUF's competition here
NMLSF vs CSBTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CSBTF has a market cap of 1.2B. Regarding current trading prices, NMLSF is priced at $0.08, while CSBTF trades at $29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CSBTF's P/E ratio is 368.75. In terms of profitability, NMLSF's ROE is +41.60%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, NMLSF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CSBTF's competition here
NMLSF vs PPTDF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, NMLSF is priced at $0.08, while PPTDF trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas PPTDF's P/E ratio is -46.11. In terms of profitability, NMLSF's ROE is +41.60%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, NMLSF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check PPTDF's competition here
NMLSF vs NURPF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, NMLSF is priced at $0.08, while NURPF trades at $8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas NURPF's P/E ratio is 51.38. In terms of profitability, NMLSF's ROE is +41.60%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, NMLSF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check NURPF's competition here
NMLSF vs IDRSF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, IDRSF has a market cap of 1B. Regarding current trading prices, NMLSF is priced at $0.08, while IDRSF trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas IDRSF's P/E ratio is -6.11. In terms of profitability, NMLSF's ROE is +41.60%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, NMLSF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check IDRSF's competition here
NMLSF vs BTTAY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, NMLSF is priced at $0.08, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, NMLSF's ROE is +41.60%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, NMLSF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BTTAY's competition here
NMLSF vs TKBIF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, NMLSF is priced at $0.08, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, NMLSF's ROE is +41.60%, compared to TKBIF's ROE of N/A. Regarding short-term risk, NMLSF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NMLSF.Check TKBIF's competition here
NMLSF vs BPMUF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, NMLSF is priced at $0.08, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, NMLSF's ROE is +41.60%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, NMLSF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BPMUF's competition here
NMLSF vs VBIZF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, VBIZF has a market cap of 622.3M. Regarding current trading prices, NMLSF is priced at $0.08, while VBIZF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas VBIZF's P/E ratio is 29.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, NMLSF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check VBIZF's competition here
NMLSF vs IVEVF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, NMLSF is priced at $0.08, while IVEVF trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, NMLSF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check IVEVF's competition here
NMLSF vs INRLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, INRLF has a market cap of 605.8M. Regarding current trading prices, NMLSF is priced at $0.08, while INRLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas INRLF's P/E ratio is -4.51. In terms of profitability, NMLSF's ROE is +41.60%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, NMLSF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check INRLF's competition here
NMLSF vs CKDXF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, NMLSF is priced at $0.08, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, NMLSF's ROE is +41.60%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, NMLSF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CKDXF's competition here
NMLSF vs GNFTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, GNFTF has a market cap of 544.4M. Regarding current trading prices, NMLSF is priced at $0.08, while GNFTF trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas GNFTF's P/E ratio is -12.22. In terms of profitability, NMLSF's ROE is +41.60%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, NMLSF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check GNFTF's competition here
NMLSF vs SOLTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SOLTF has a market cap of 493.2M. Regarding current trading prices, NMLSF is priced at $0.08, while SOLTF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SOLTF's P/E ratio is -6.26. In terms of profitability, NMLSF's ROE is +41.60%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, NMLSF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SOLTF's competition here
NMLSF vs RAONF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, NMLSF is priced at $0.08, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas RAONF's P/E ratio is -43.33. In terms of profitability, NMLSF's ROE is +41.60%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, NMLSF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for NMLSF.Check RAONF's competition here
NMLSF vs GNFTY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, NMLSF is priced at $0.08, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, NMLSF's ROE is +41.60%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, NMLSF is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check GNFTY's competition here
NMLSF vs BOVNF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, NMLSF is priced at $0.08, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, NMLSF's ROE is +41.60%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, NMLSF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BOVNF's competition here
NMLSF vs TBGNF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, NMLSF is priced at $0.08, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, NMLSF's ROE is +41.60%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, NMLSF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check TBGNF's competition here
NMLSF vs CLVLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, NMLSF is priced at $0.08, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, NMLSF's ROE is +41.60%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, NMLSF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CLVLF's competition here
NMLSF vs AVCTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, AVCTF has a market cap of 400.3M. Regarding current trading prices, NMLSF is priced at $0.08, while AVCTF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas AVCTF's P/E ratio is -6.10. In terms of profitability, NMLSF's ROE is +41.60%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, NMLSF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check AVCTF's competition here
NMLSF vs PTCHF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, PTCHF has a market cap of 374.8M. Regarding current trading prices, NMLSF is priced at $0.08, while PTCHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas PTCHF's P/E ratio is 9.12. In terms of profitability, NMLSF's ROE is +41.60%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, NMLSF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check PTCHF's competition here
NMLSF vs CLVLY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CLVLY has a market cap of 363M. Regarding current trading prices, NMLSF is priced at $0.08, while CLVLY trades at $7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CLVLY's P/E ratio is 16.07. In terms of profitability, NMLSF's ROE is +41.60%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, NMLSF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CLVLY's competition here
NMLSF vs CYDY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CYDY has a market cap of 353.2M. Regarding current trading prices, NMLSF is priced at $0.08, while CYDY trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CYDY's P/E ratio is -9.27. In terms of profitability, NMLSF's ROE is +41.60%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, NMLSF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CYDY's competition here
NMLSF vs CMVLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, NMLSF is priced at $0.08, while CMVLF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas CMVLF's P/E ratio is -13.64. In terms of profitability, NMLSF's ROE is +41.60%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, NMLSF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check CMVLF's competition here
NMLSF vs NWBO Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, NWBO has a market cap of 323.4M. Regarding current trading prices, NMLSF is priced at $0.08, while NWBO trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas NWBO's P/E ratio is -3.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, NMLSF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check NWBO's competition here
NMLSF vs NGENF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, NMLSF is priced at $0.08, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas NGENF's P/E ratio is -15.19. In terms of profitability, NMLSF's ROE is +41.60%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, NMLSF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check NGENF's competition here
NMLSF vs HLOSF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, HLOSF has a market cap of 312.5M. Regarding current trading prices, NMLSF is priced at $0.08, while HLOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas HLOSF's P/E ratio is -15.88. In terms of profitability, NMLSF's ROE is +41.60%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, NMLSF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check HLOSF's competition here
NMLSF vs FGHQF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, NMLSF is priced at $0.08, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, NMLSF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check FGHQF's competition here
NMLSF vs PBBIF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, NMLSF is priced at $0.08, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, NMLSF's ROE is +41.60%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, NMLSF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check PBBIF's competition here
NMLSF vs SLNCF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SLNCF has a market cap of 283.4M. Regarding current trading prices, NMLSF is priced at $0.08, while SLNCF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SLNCF's P/E ratio is -3.17. In terms of profitability, NMLSF's ROE is +41.60%, compared to SLNCF's ROE of -4.29%. Regarding short-term risk, NMLSF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SLNCF's competition here
NMLSF vs SPHDF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SPHDF has a market cap of 283.1M. Regarding current trading prices, NMLSF is priced at $0.08, while SPHDF trades at $20.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SPHDF's P/E ratio is -2.99. In terms of profitability, NMLSF's ROE is +41.60%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, NMLSF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SPHDF's competition here
NMLSF vs KNTPF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, KNTPF has a market cap of 265M. Regarding current trading prices, NMLSF is priced at $0.08, while KNTPF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas KNTPF's P/E ratio is -9.42. In terms of profitability, NMLSF's ROE is +41.60%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, NMLSF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check KNTPF's competition here
NMLSF vs ORPOF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, NMLSF is priced at $0.08, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, NMLSF's ROE is +41.60%, compared to ORPOF's ROE of N/A. Regarding short-term risk, NMLSF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ORPOF's competition here
NMLSF vs HNSBF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, NMLSF is priced at $0.08, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas HNSBF's P/E ratio is -4.20. In terms of profitability, NMLSF's ROE is +41.60%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, NMLSF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check HNSBF's competition here
NMLSF vs OPORF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, OPORF has a market cap of 240.9M. Regarding current trading prices, NMLSF is priced at $0.08, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas OPORF's P/E ratio is 35.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to OPORF's ROE of +0.12%. Regarding short-term risk, NMLSF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check OPORF's competition here
NMLSF vs NWPHF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, NMLSF is priced at $0.08, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas NWPHF's P/E ratio is N/A. In terms of profitability, NMLSF's ROE is +41.60%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, NMLSF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check NWPHF's competition here
NMLSF vs ORYZF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ORYZF has a market cap of 238.9M. Regarding current trading prices, NMLSF is priced at $0.08, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ORYZF's P/E ratio is -75.75. In terms of profitability, NMLSF's ROE is +41.60%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, NMLSF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ORYZF's competition here
NMLSF vs FPHAF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, NMLSF is priced at $0.08, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, NMLSF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check FPHAF's competition here
NMLSF vs MLLCF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, MLLCF has a market cap of 185.5M. Regarding current trading prices, NMLSF is priced at $0.08, while MLLCF trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas MLLCF's P/E ratio is -2.37. In terms of profitability, NMLSF's ROE is +41.60%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, NMLSF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for NMLSF.Check MLLCF's competition here
NMLSF vs RECEF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, RECEF has a market cap of 182.6M. Regarding current trading prices, NMLSF is priced at $0.08, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas RECEF's P/E ratio is -8.33. In terms of profitability, NMLSF's ROE is +41.60%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, NMLSF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for NMLSF.Check RECEF's competition here
NMLSF vs ADOCY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, NMLSF is priced at $0.08, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, NMLSF's ROE is +41.60%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, NMLSF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check ADOCY's competition here
NMLSF vs BRIBF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BRIBF has a market cap of 166.6M. Regarding current trading prices, NMLSF is priced at $0.08, while BRIBF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BRIBF's P/E ratio is -2.89. In terms of profitability, NMLSF's ROE is +41.60%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, NMLSF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BRIBF's competition here
NMLSF vs SCNLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SCNLF has a market cap of 150.5M. Regarding current trading prices, NMLSF is priced at $0.08, while SCNLF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SCNLF's P/E ratio is -14.50. In terms of profitability, NMLSF's ROE is +41.60%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, NMLSF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SCNLF's competition here
NMLSF vs JWCTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, JWCTF has a market cap of 147.5M. Regarding current trading prices, NMLSF is priced at $0.08, while JWCTF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas JWCTF's P/E ratio is -1.61. In terms of profitability, NMLSF's ROE is +41.60%, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, NMLSF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check JWCTF's competition here
NMLSF vs BBIXF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, BBIXF has a market cap of 140.2M. Regarding current trading prices, NMLSF is priced at $0.08, while BBIXF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas BBIXF's P/E ratio is -12.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, NMLSF is more volatile compared to BBIXF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check BBIXF's competition here
NMLSF vs AMGXF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, NMLSF is priced at $0.08, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, NMLSF's ROE is +41.60%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, NMLSF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check AMGXF's competition here
NMLSF vs SPHRF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SPHRF has a market cap of 138.6M. Regarding current trading prices, NMLSF is priced at $0.08, while SPHRF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SPHRF's P/E ratio is -33.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, NMLSF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SPHRF's competition here
NMLSF vs SPHRY Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, SPHRY has a market cap of 136.5M. Regarding current trading prices, NMLSF is priced at $0.08, while SPHRY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas SPHRY's P/E ratio is -54.17. In terms of profitability, NMLSF's ROE is +41.60%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, NMLSF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check SPHRY's competition here
NMLSF vs HBPCF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, NMLSF is priced at $0.08, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, NMLSF's ROE is +41.60%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, NMLSF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check HBPCF's competition here
NMLSF vs TRGNF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, NMLSF is priced at $0.08, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, NMLSF's ROE is +41.60%, compared to TRGNF's ROE of -6.34%. Regarding short-term risk, NMLSF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check TRGNF's competition here
NMLSF vs IPHYF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, IPHYF has a market cap of 128.7M. Regarding current trading prices, NMLSF is priced at $0.08, while IPHYF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas IPHYF's P/E ratio is -2.11. In terms of profitability, NMLSF's ROE is +41.60%, compared to IPHYF's ROE of -6.59%. Regarding short-term risk, NMLSF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check IPHYF's competition here
NMLSF vs AAPGV Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, NMLSF is priced at $0.08, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas AAPGV's P/E ratio is N/A. In terms of profitability, NMLSF's ROE is +41.60%, compared to AAPGV's ROE of -2.49%. Regarding short-term risk, NMLSF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check AAPGV's competition here
NMLSF vs MSCLF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, MSCLF has a market cap of 123.8M. Regarding current trading prices, NMLSF is priced at $0.08, while MSCLF trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas MSCLF's P/E ratio is 3.12. In terms of profitability, NMLSF's ROE is +41.60%, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, NMLSF is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check MSCLF's competition here
NMLSF vs PSTTF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, NMLSF is priced at $0.08, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, NMLSF's ROE is +41.60%, compared to PSTTF's ROE of N/A. Regarding short-term risk, NMLSF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check PSTTF's competition here
NMLSF vs NDTP Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, NDTP has a market cap of 112M. Regarding current trading prices, NMLSF is priced at $0.08, while NDTP trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas NDTP's P/E ratio is -2.41. In terms of profitability, NMLSF's ROE is +41.60%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, NMLSF is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check NDTP's competition here
NMLSF vs EPRXF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, NMLSF is priced at $0.08, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, NMLSF's ROE is +41.60%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, NMLSF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for NMLSF.Check EPRXF's competition here
NMLSF vs POLBF Comparison March 2026
NMLSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMLSF stands at 2.9M. In comparison, POLBF has a market cap of 106.5M. Regarding current trading prices, NMLSF is priced at $0.08, while POLBF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMLSF currently has a P/E ratio of -1.97, whereas POLBF's P/E ratio is -7.55. In terms of profitability, NMLSF's ROE is +41.60%, compared to POLBF's ROE of -0.54%. Regarding short-term risk, NMLSF is less volatile compared to POLBF. This indicates potentially lower risk in terms of short-term price fluctuations for NMLSF.Check POLBF's competition here